Q3 2010

Filed Nov 12, 2010 · 10-Q · 43 days after period end · 0000109657-10-000035

Q3 2010 · 10-Q

Revenue

$0.00

no prior Q3 2009 on file

Net Income

-$633.00K

no prior Q3 2009 on file

EPS Diluted

$0.01

no prior Q3 2009 on file

Gross Profit$0—

Operating Income

Same quarter

no prior Q3 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Sep 30, 2010 · filed Nov 12, 2010 · 43 d after period end

GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR